Anticarcinogenic effects of synthetic phenolic antioxidants

Oxidants, Antioxidants, and Free Radicals

Volumn , Issue , 2017, Pages 341-350

  Williams, Gary M ^a   Iatropoulos, Michael J ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84961889265     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780203744673     Document Type: Chapter

References (35)

1. Wattenberg L. W. 1972. Inhibition of carcinogenic and toxic effects of polycyclic hydrocarbons by phenolic antioxidants and ethoxyquin. J, Natl. Cancer Inst. 48:1425-1430.
2. Talalay, P., and Benson A. M. 1982. Elevation of quinone reductase activity by anticarcinogenic antioxidants. Adv. Enzyme Regul. 20:28-30.
3. Wattenberg, L. W. 1985. Chemoprevendon of cancer. Cancer Res. 45:1-8.
4. Williams, G. M. 1993. Inhibition of chemical-induced experimental cancer by synthetic phenolic antioxidants. In Antioxidants: Chemical. Physiological, Nutritional and Toxicological Aspects, eds. G. M. Williams, H. Sies G. T. Baker III J. W. Erdman, Jr., and C. J. Henry, pp. 303-308. Princeton, NJ: Princeton Scientific Press.
5. Tanaka, T., Maruyama, H., Maeura Y., Weisburger J. H., and Williams G. M. 1991. Modulation by butylated hydroxy toluene of liver and bladder carcinogenesis induced by chronic low level exposure to 2-acetylaminofluorene. Cancer Res. 51:6224-5230.
6. Williams, G. M. and latropoulos M. J. 1996. Inhibition of the hepatocarcinogenicity of aflatoxin B, in rats by low levels of the phenolic antioxidants butylated hydroxyanisole and butylated hydroxytoluene. Cancer Lett. 104:49-53.
7. Furukawa K., Maeura Y., Furukawa, N. T. and Williams G. M. 1984. Induction by butylated hydroxytol-uene of rat liver gamma-glutamyltranspeptidase activity in comparison to expression in carcinogen-induced altered lesions. Chem. Biol. Interact. 48:43-58.
8. Williams G. M. 1994. Interventive prophylaxis of liver cancer. Eur. J. Cancer Prev. 3:89-99.
9. Williams G. M., Maeura Y., and Weisburger J. H. 1983. Simultaneous inhibition of liver carcinogenicity and enhancement of bladder carcinogenicity of W-2-fluorenylacetamide by butylated hydroxytoluene. Cancer Lett. 19:50-60.
10. Maeura Y., Weisburger J. H., and Williams G. M. 1984. Dose-dependent reduction of N-2-fluorenylace-tamide-induced liver cancer and enhancement of bladder cancer in rats by butylated hydroxytoluene. Cancer Res. 44:1604-1610.
11. Williams G. M., Tanaka T., Maruyama H., Maeura Y., Weisburger J. H., and Zang E. 1991. Modulation by butylated hydroxytoluene of liver and bladder carcinogenesis induced by chronic low level exposure to 2-acetylaminofluorene. Cancer Res. 51:6224-6230.
12. Williams G. M., Tanaka T., and Maeura Y. 1986. Dose-dependent inhibition of aflatoxin B, induced hepatocarcinogenesis by the phenolic antioxidants, butylated hydroxyanisole and butylated hydroxytoluene. Carcinogenesis 7:1043-1050.
13. Williams G. M., and Watanabe K. 1978. Quantitative kinetics of development of N -2-11 uoreny 1 accta-mide-induced. altered (hyperplastic) hepatocellular foci resistant to iron accumulation and of their reversion of persistence following removal of carcinogen. J. Natl. Cancer Inst. 61:113-121.
14. Rutenberg A. M., Kim, H., Fishbein, J., Hanker, J. S., Wasserkrug H. C., and Seligman R. 1968. Histochemical and ultrastructural demonstration of gamma-glutamyl transpeptidase activity. J. Histo-chem. Cytochem. 17:517-526.
15. Shimizu A., Nakamura Y., Harada, M., Ono T., Sato K., lnone T., and Kawisawa, M. 1989. Positive foci of glutathione S-transferase placental form in the liver of rats given furfural by oral administration. Jpn. J. Cancer Res. 80:608-611.
16. Scheffe H. 1959. The Analysis of Variance. Wiley. New York.
17. Grantham P. H., Weisburger J. H., and Weisburger E. K. 1973. Effect of the antioxidanl butylated hydroxytoluene (BHT) on the metabolism of the carcinogens N-2-fluorenylacetamide. Food Cosmet. Toxicol. 11:209-217.
18. Ito N., Fukushima S., and Tsuda H. 1985. Carcinogenicity and modification of the carcinogenic response by BHA. BHT and other antioxidants. CRC Crit. Rev. Toxicol. 15:109-150.
19. Chipman J. K., and Davies, J. E. 1988. Reduction of 2-acetylaminofluorene-induced unscheduled DNA synthesis in human and rat hepatocytes by butylated hydroxytoluene. Mutai. Res. 207:193-198.
20. Richer N., Marion M., and Denzeau, F. 1989. Inhibition of binding of 2-acetylaminofluorene to DNA by butylated hydroxytoluene and butylated hydroxyanisole in vitro. Cancer Lett. 47:211-216.
21. Mikuni T., Tasuta M., and Kamachi M. 1987. Scavanging effect of butylated hydroxytoluene on the production of free radicals by the reaction of hydrogen peroxide with N -ethyl- N′-nitrosoguanidine. J. Natl. Cancer Inst. 79:281-283.
22. rDNA binding in rats. Cancer Lett. 24:241-250.
23. Williams, G. M., McQueen C. A., and Tong C. 1990. Butylated hydroxyanisole and butylated hydroxytoluene 1. Genetic toxicology studies. Food Chem. Toxicol. 28:793-798.
24. Williams, G. M. 1986. Epigenetic promoting effects of butylated hydroxyanisole. Food Chem. Toxicol. 24:1163-1166.
25. Williams G. M. 1987. Definition of a human cancer hazard. In Nongenotoxic Mechanisms in Carcinogenesis. Banbury Report 25, pp. 367-380. Cold Spring Harbor. NY: Cold Spring Harbor Laboratory.
26. Williams G. M., Karbe E., Fenner-Crisp P. A., Latropoulos M. J., and Weisburger J. H. 1996. Risk assessment of carcinogenesis in food with special consideration of non-genotoxic carcinogens. Scientific arguments for use of risk assessment and for changing the Delaney Clause specifically. Exp. Toxicol. Pathol. 48:209-215.
27. Whysner J., and Williams G.M. 1996. Butylated hydroxyanisole mechanistic data and risk assessment: Conditional species-specific cytotoxicity, enhanced cell proliferation and tumor promotion. Pharmacol. Ther. 71:137-151.
28. 1 in rats. Cancer Lett. 19:125-132.
29. Birt D. F. 1986. Update on the effects of vitamins A, C. and E and selenium on carcinogenesis. Proc. Soc. Exp. Biol. Med. 183:311-320.
30. Rogers A. E., and Longnecker M. P. 1988. Dietary and nutritional influences on cancer: A review of epidemiologic and experimental data. Lab. Invest. 59:729-759.
31. Ulland B. J., Weisburger J. H., Yamamoto R., and Weisburger E. K. 1973. Antioxidants and carcinogenesis: Butylated hydroxytoluene. but not diphenyl-p-phenylenediamine. inhibits cancer induction by N-2-fluorenylacetamide in rats. Food Cosmet. Toxicol. 11:199-207.
32. Weisburger E. K., Evarts R. P., and Wenk M. L. 1977. Inhibitory effect of butylated hydroxytoluene (BHT) on intestinal carcinogenesis in rats by azoxymethane. Food Cosmet. Toxicol. 15:139-141.
33. Cohen L. A., Polansky M., Furuya K., Reddy, M., Berke B., and Weisburger J. H. 1984. Inhibition of chemically induced mammary carcinogenesis in rats by short-term exposure to butylated hydroxytoluene (BHT): Interrelationships among BHT concentration, carcinogen dose, and diet. J. Nail. Cancer Inst. 72:165-172.
34. Reddy S. B., Maeura Y., and Weisburger J. H. 1983. Effect of various levels of dietary butylated hydroxyanisole on methylazoxymethanol acetate-induced colon carcinogenesis in CFI mice. J. Natl. Cancer Inst. 71:1299-1305.
35. Chung F. L., Wang M., Carmella, S. G., and Hecht S. S. 1986. Effects of butylated hydroxyanisole on the tumorigenicity and metabolism of N -nitrosodimethylamine and N-nitrosopyrrolidine in A/J mice. Cancer Res. 46:165-168.